Multifaceted interconnections between macrophage migration inhibitory factor and psychiatric disorders

Prog Neuropsychopharmacol Biol Psychiatry. 2022 Jan 10:112:110422. doi: 10.1016/j.pnpbp.2021.110422. Epub 2021 Aug 4.

Abstract

Inflammation is involved in the pathogenesis of psychiatric disorders. Many previous studies have defined the important roles of inflammatory factors in the pathogenesis, diagnosis, and treatment outcomes of psychiatric disorders. Macrophage migration inhibitory factor (MIF), a pro-inflammatory factor, has been gradually recognized to be involved in the development of neurological diseases in recent years. Our current review focuses on discussing the potential beneficial and detrimental roles of MIF in psychiatric disorders. We will provide new mechanistic insights for the development of potential diagnostic and therapeutic biomarkers based on MIF for psychiatric diseases.

Keywords: Alzheimer's disease; Depressive disorder; Inflammation; Psychiatric disorders; Schizophrenia.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Alzheimer Disease / immunology
  • Animals
  • Biomarkers*
  • Depression / immunology
  • Humans
  • Inflammation*
  • Macrophage Migration-Inhibitory Factors / immunology*
  • Mental Disorders / immunology*
  • Nervous System Diseases
  • Schizophrenia / immunology

Substances

  • Biomarkers
  • Macrophage Migration-Inhibitory Factors